Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV6U0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,034
Award facts
- Contract value 100% obligated
- $55,033.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $55,033.85 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is fulfilling this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a total value of $999,999,999.00 through December 2026.
Dupixent is a prescription biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic conditions. The delivery order represents a single transaction within AmerisourceBergen's comprehensive pharmaceutical supply relationship with the Defense Logistics Agency, which supports military healthcare systems, the Defense Health Agency, and other federal healthcare programs. The contractor's extensive portfolio of federal contract awards demonstrates its capability to manage complex pharmaceutical procurement and delivery operations at scale across multiple therapeutic domains and geographic regions.
Quick answers
Who was awarded contract SPE2DR26FV6U0?
SPE2DR26FV6U0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FV6U0 worth?
The government has obligated $55,034 on SPE2DR26FV6U0.
Is contract SPE2DR26FV6U0 an order under another contract?
Yes. SPE2DR26FV6U0 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV6U0 competed?
The extent of competition for SPE2DR26FV6U0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award